Szpital Specjalistyczny nr 1; Oddzial Okulistyki
About Szpital Specjalistyczny nr 1; Oddzial Okulistyki
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Szpital Specjalistyczny nr 1; Oddzial Okulistyki
During the past decade, Szpital Specjalistyczny nr 1; Oddzial Okulistyki conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
2010-08-01
2013-08-01
Completed
173
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
2010-09-16
2019-02-14
Completed
1,717
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
2011-09-21
2024-06-30
Active, not recruiting
118
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
2012-05-01
2031-03-01
Active, not recruiting
504
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
2013-02-01
2015-08-01
Completed
203
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki"
#1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Szpital Specjalistyczny nr 1; Oddzial Okulistyki
According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" are
"Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Macular Edema" (2 trials), "Branch Retinal Vein Occlusion" (1 trials) and "Central Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" in a lesser frequency.
Clinical Trials Intervention Types at Szpital Specjalistyczny nr 1; Oddzial Okulistyki
Most popular intervention types in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" are "Drug" (8 trials), "Other" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (6 trials), "Aflibercept" (4 trials), "Lampalizumab" (2 trials) and "No intervention" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital Specjalistyczny nr 1; Oddzial Okulistyki
The vast majority of trials in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki" are
9 trials for "All" genders.
Clinical Trials Status at Szpital Specjalistyczny nr 1; Oddzial Okulistyki
Currently, there are NaN active trials in "Szpital Specjalistyczny nr 1; Oddzial Okulistyki".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Szpital Specjalistyczny nr 1; Oddzial Okulistyki,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Specjalistyczny nr 1; Oddzial Okulistyki, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".